Hemostemix Closes $1,644,000 Offering
September 02, 2016 16:05 ET
|
Hemostemix Inc.
TORONTO, ONTARIO--(Marketwired - Sept. 2, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM) (OTCQX:HMTXF) today announces it has closed its private placement...
Hemostemix Inc. Reminds Shareholders to Vote the WHITE Proxy in Favour of the Current Trusted Board
September 01, 2016 08:30 ET
|
Hemostemix Inc.
TORONTO, ONTARIO--(Marketwired - Sept. 1, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM)(OTCQX:HMTXF) thanks shareholders for their overwhelming support for...
Hemostemix Voids Taiwanese Agreement
August 29, 2016 17:38 ET
|
Hemostemix Inc.
TORONTO, ONTARIO--(Marketwired - Aug. 29, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company) (TSX VENTURE:HEM) (OTCQX:HMTXF), a clinical-stage autologous cell-therapy company,...
Hemostemix Issues Letter to Shareholders Urging Them to Vote Their WHITE Proxy
August 29, 2016 08:30 ET
|
Hemostemix Inc
TORONTO, ONTARIO--(Marketwired - Aug. 29, 2016) -
Warns shareholders the dissident nominees will put their investment at risk.
Encourages...
Hemostemix Announces Corporate Updates
June 28, 2016 16:01 ET
|
Hemostemix Inc.
TORONTO, ONTARIO--(Marketwired - June 28, 2016) -
NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Hemostemix Inc. ("Hemostemix" or...
Hemostemix Announces Resignations
May 20, 2016 16:31 ET
|
Hemostemix Inc.
TORONTO, ONTARIO--(Marketwired - May 20, 2016) -
NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Hemostemix Inc. ("Hemostemix" or...
Hemostemix Announces Non-Brokered Private Placement
April 20, 2016 16:21 ET
|
Hemostemix Inc.
TORONTO, ONTARIO--(Marketwired - April 20, 2016) -
NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Hemostemix Inc. ("Hemostemix" or...
Hemostemix Receives IRB Approval from the Houston Methodist Hospital Research Institute and the University of California Los Angeles
April 18, 2016 08:30 ET
|
Hemostemix Inc.
TORONTO, ONTARIO--(Marketwired - April 18, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM)(OTCQX:HMTXF), a clinical-stage autologous cell-therapy company, is...
Hemostemix Appoints Robert Achtymichuk as Vice President, Business Development
March 31, 2016 08:30 ET
|
Hemostemix Inc.
TORONTO, ONTARIO--(Marketwired - March 31, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM)(OTCQX:HMTXF), a clinical-stage autologous cell therapy company,...
Hemostemix Issues Corporate Update From CEO Elmar Burchardt
February 03, 2016 09:36 ET
|
Hemostemix Inc.
TORONTO, ONTARIO--(Marketwired - Feb. 3, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM)(OTCQX:HMTXF), a clinical-stage autologous cell-therapy company, released...